Home / News / Health / Researchers develop a new compound to treat Autism
Symbol of Autism rights movement
Symbol of Autism rights movement

Researchers develop a new compound to treat Autism

New Delhi, Nov 17: A group of Indian researchers has developed a compound that promises to offer a better treatment for Autism Spectrum Disorder. They have found in studies with a mouse model that it had the potential to improve daily activities like learning and recollecting new tasks in patients suffering from the disorder.

What is Autism Spectrum Disorder?

Autism Spectrum Disorder is one of the major health issues causing a tremendous burden to human society. Despite strenuous efforts around the world, there still is no drug available to treat it. Current therapeutics aim to only alleviate symptoms such as epileptic seizures or sleep issues but not to treat the multiple problems of the disorder.

A major challenge in finding therapeutics to treat it is to help the patients perform their daily activities with efficiency close to that of a healthy person.

In the new study, researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous research institute of the Department of Science & Technology (DST), Government of India, have developed a compound that has demonstrated a potential to restore neuronal function, learning and memory, and reduce epileptic seizures in a mouse model.

Interestingly, the study showed that the compound restored the neural functions not only when administered during development (the equivalent of babies (1-2 years)) and childhood stages (3-6 years)) but also after mid-childhood (7-11 years) when most of the brain regions are considered to have formed properly.

Previous studies have attributed disruption in optimal brain development, mainly neuronal connections, during the early stage of development (i.e., babies/childhood) as one of the causes of the disorder. Due to the altered brain development, information processing becomes aberrant, and understanding simple tasks becomes exceptionally challenging for patients suffering from it.

Using electrophysiology, which helps understand how neurons communicate, and behavioural experiments, which indicates the overall brain function, the JNCASR team has shown that the new compound named 6BIO can restore the information processing in the mouse model. Thus, it has a strong potential as a therapeutic to treat the disorder.

The researchers have published a report on their study in the journal Experimental Brain Research. The team consisted of Vijaya Verma, M. J. Vijay Kumar, Kavita Sharma, Sridhar Rajaram, Ravi Muddashetty, Ravi Manjithaya, Thomas Behnisch, and James P. Clement.

Topics: mouse model, learning, therapeutics, symptom, epileptic seizure, healthy, Jawaharlal Nehru Centre for Advanced Scientific Research, JNCASR, Department of Science and Technology, DST, neuronal function, memory, childhood, brain, electrophysiology, behavioural experiments,

Sharing is caring!

About hastakshep news

Check Also

Top 10 headlines this night

#Breaking: Top headlines of India today. The latest breaking news in India | 25 November 2021

PM Modi lays foundation stone of Jewar Airport Prime Minister Narendra Modi lays the foundation …

This site uses Akismet to reduce spam. Learn how your comment data is processed.

shares